Lazard Asset Management
NTUS

Lazard Asset Management’s Natus Medical Inc NTUS Stock Holding History

Lazard Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,082
Closed -$100K – 2631
2022
Q2 		$100K Buy
3,082
+87
+3% +$2.75K ﹤0.01% 1512
2022
Q1 		$78K Buy
2,995
+193
+7% +$4.71K ﹤0.01% 1517
2021
Q4 		$66K Buy
2,802
+281
+11% +$6.93K ﹤0.01% 1625
2021
Q3 		$63K Buy
+2,521
New +$64.2K ﹤0.01% 1578
2020
Q4 		– Sell
-2,358
Closed -$40K – 2035
2020
Q3 		$40K Sell
2,358
-385
-14% -$7.28K ﹤0.01% 1251
2020
Q2 		$59K Buy
+2,743
New +$62.8K ﹤0.01% 1186
2016
Q3 		– Sell
-27,250
Closed -$1.03M – 1057
2016
Q2 		$1.03M Sell
27,250
-108,508
-80% -$3.63M ﹤0.01% 685
2016
Q1 		$5.22M Buy
135,758
+7,951
+6% +$296K 0.01% 491
2015
Q4 		$6.14M Sell
127,807
-50,545
-28% -$2.34M 0.01% 486
2015
Q3 		$7.04M Buy
178,352
+44,982
+34% +$1.91M 0.02% 434
2015
Q2 		$5.68M Buy
133,370
+42,695
+47% +$1.7M 0.01% 500
2015
Q1 		$3.58M Buy
90,675
+37,307
+70% +$1.38M 0.01% 576
2014
Q4 		$1.92M Buy
+53,368
New +$1.79M ﹤0.01% 673

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lazard Asset Management's NTUS Position: Q3 2022 in Review

Lazard Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 3,082 shares — an estimated $100K sold.

Lazard Asset Management first reported a position in NTUS in Q4 2014 and held it in 13 quarters. The position peaked at $7.04M in Q3 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Lazard Asset Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Lazard Asset Management sold 3,082 Natus Medical Inc shares in Q3 2022, an estimated $100K.
  • Lazard Asset Management first reported a position in Natus Medical Inc in Q4 2014 and held it in 13 quarters.
  • Lazard Asset Management's Natus Medical Inc position peaked at $7.04M in Q3 2015.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.